Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?

[1]  L. Boero,et al.  Comparison of two immunoassays in the determination of IGF-I levels and its correlation with oral glucose tolerance test (OGTT) and with clinical symptoms in acromegalic patients , 2012, Pituitary.

[2]  F. Minuto,et al.  Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience , 2012, Pituitary.

[3]  P. Rosário,et al.  Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units , 2012, Pituitary.

[4]  E. Laws,et al.  Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. , 2011, The Journal of clinical endocrinology and metabolism.

[5]  E. Chang,et al.  Excess mortality for patients with residual disease following resection of pituitary adenomas , 2011, Pituitary.

[6]  D. Clemmons.  Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. , 2011, Clinical chemistry.

[7]  D. Clemmons.  Clinical laboratory indices in the treatment of acromegaly. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[8]  Harn-Shen Chen,et al.  The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[9]  M. Fleseriu,et al.  Acromegaly: a review of current medical therapy and new drugs on the horizon. , 2010, Neurosurgical focus.

[10]  P. Chanson,et al.  A consensus on criteria for cure of acromegaly. , 2010, The Journal of clinical endocrinology and metabolism.

[11]  A. Barkan,et al.  Basal, But Not Pulsatile, Growth Hormone Secretion Determines the Ambient Circulating Levels of Insulin-Like Growth Factor-I , 2010 .

[12]  Alberto Fernández,et al.  Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) , 2010, Clinical endocrinology.

[13]  H. Machado,et al.  Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity. , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[14]  N. Karavitaki,et al.  The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly , 2009, Clinical endocrinology.

[15]  S. Melmed.  Acromegaly pathogenesis and treatment. , 2009, The Journal of clinical investigation.

[16]  R. Clayton,et al.  ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. , 2009, The Journal of clinical endocrinology and metabolism.

[17]  P. Freda.  Monitoring of acromegaly: what should be performed when GH and IGF‐1 levels are discrepant? , 2009, Clinical endocrinology.

[18]  P. Chanson,et al.  D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. , 2009, European journal of endocrinology.

[19]  R. Clayton,et al.  Monitoring disease activity using GH and IGF‐I in the follow‐up of 501 patients with acromegaly , 2009, Clinical endocrinology.

[20]  S. Melmed,et al.  The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. , 2009, The Journal of clinical endocrinology and metabolism.

[21]  M. Gadelha,et al.  Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR. , 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[22]  H. Wittchen,et al.  High prevalence of biochemical acromegaly in primary care patients with elevated IGF‐1 levels , 2008, Clinical endocrinology.

[23]  B. Velkeniers,et al.  Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly. , 2008, The Journal of clinical endocrinology and metabolism.

[24]  A. Pfeiffer,et al.  Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. , 2008, The Journal of clinical endocrinology and metabolism.

[25]  S. Melmed.  Medical progress: Acromegaly. , 2006, The New England journal of medicine.

[26]  A. Beckers,et al.  High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. , 2006, The Journal of clinical endocrinology and metabolism.

[27]  L. Niskanen,et al.  A nationwide survey of mortality in acromegaly. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  S. Ezzat,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF ACROMEGALY , 2004 .

[29]  S. Ferris,et al.  Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. , 2004, The Journal of clinical endocrinology and metabolism.

[30]  G. Gamble,et al.  Factors influencing mortality in acromegaly. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  I. Holdaway,et al.  Epidemiology of Acromegaly , 1999, Pituitary.

[32]  S. Ezzat,et al.  AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[33]  G. Heinze,et al.  Use of the oral glucose tolerance test to define remission in acromegaly. , 2003, Metabolism: clinical and experimental.

[34]  S. Wardlaw,et al.  Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. , 1998, Journal of neurosurgery.